BackMallinckrodt Plc - New Overview

Mallinckrodt Plc - New Net Income

Track Mallinckrodt Plc - New's net income ($-800M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$220.50M
9287.5% YoY

As of Jun 2026

Annual Net Income (TTM)

-$798.20M
145.97% YoY

Trailing 12 months ending Jun 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Mallinckrodt Plc - New (MNK) FAQ

As of the most recent data (June 2026), MNK shows a net income of $-800M. That compares with $1.7B in the prior-year period — down 146.0% year over year. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MNK's net income is now $-800M (was $1.7B) — a 146.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Mallinckrodt Plc - New is outperforming or lagging.

The Healthcare sector average net income is about $16B. Mallinckrodt Plc - New is at $-800M, which is lower that average. That is roughly 104.8% below the sector mean. Use the comparison chart on this page to see how MNK stacks up against individual peers as well.

Tracking MNK's net income over time shows whether Mallinckrodt Plc - New is scaling, shrinking, or reshaping that part of the business. The current reading is $-800M That compares with $1.7B in the prior-year period — down 146.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has Mallinckrodt Plc - New's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-800M) with ownership activity and broader fundamentals.